Abstract | BACKGROUND: METHODS: RESULTS: CONCLUSIONS: GENERAL SIGNIFICANCE: The data presented here provides evidence that ATM, ATR and DNA- PKcs involved in DDR are not only promising biomarkers but are also rational targets for personalized therapy in ovarian cancer.
|
Authors | Tarek M A Abdel-Fatah, Arvind Arora, Paul Moseley, Clare Coveney, Christina Perry, Kerstie Johnson, Christopher Kent, Graham Ball, Stephen Chan, Srinivasan Madhusudan |
Journal | BBA clinical
(BBA Clin)
Vol. 2
Pg. 10-7
(Dec 2014)
ISSN: 2214-6474 [Print] Netherlands |
PMID | 26674120
(Publication Type: Journal Article)
|